Stem Cells: are cells with the potential to develop into many different types of cells in the body. They serve as a repair system for the body. There are two main types of stem cells: embryonic stem cells and adult stem cells.
CRISPR-Cas9 has been widely adapted for use in transcriptional modulation and epigenetic engineering with deactivated Cas9 (dCas9) systems to enable CRISPR interference (CRISPRi) and CRISPR...
Stem cells and organoids are revolutionising medical advancements. The journey from stem cell research to translational medicine is extensive, and maintaining quality throughout development...
The adult mammalian heart bears limited regenerative capacity, resulting in the irreversible loss of cardiomyocytes post-cardiac injury, and often culminating in end-stage heart failure. Car...
For large-scale enrichment and isolation of immune cells or stem cells for cell therapy applications, common cell purification platforms separate cells based on a single surface antigen. Enr...
Super immunodeficient mice such as the NOG-EXL and NSG-SGM3 combine severe immunodeficiency with transgenic expression of human myeloid-stimulatory cytokines. These mouse strains support an...
CRISPR-Cas9 has been widely adapted for use in transcriptional modulation and epigenetic engineering with deactivated Cas9 (dCas9) systems to enable CRISPR interference (CRISPRi) and CRISPR...
Stem cells and organoids are revolutionising medical advancements. The journey from stem cell research to translational medicine is extensive, and maintaining quality throughout development...
The adult mammalian heart bears limited regenerative capacity, resulting in the irreversible loss of cardiomyocytes post-cardiac injury, and often culminating in end-stage heart failure. Car...
For large-scale enrichment and isolation of immune cells or stem cells for cell therapy applications, common cell purification platforms separate cells based on a single surface antigen. Enr...
Super immunodeficient mice such as the NOG-EXL and NSG-SGM3 combine severe immunodeficiency with transgenic expression of human myeloid-stimulatory cytokines. These mouse strains support an...
At Thermo Fisher Scientific, our goal is to bring innovative new products and services that enable the development of more physiologically relevant disease models to help accelerate the drug...
Cimeio Therapeutics is an applied gene editing and immunotherapy company developing a portfolio of Shielded-Cell & Immunotherapy Pairsâ„¢ (SCIP). Gene editing is used to introduce single nucle...
Stem cells, particularly Induced Pluripotent Stem Cells (iPSCs), are becoming essential tools in scientific research, from drug discovery to disease modeling. As the scientific community shi...
Neural organoids derived from patient-specific iPSC lines can help open doors toward studying human brain development, physiology, and disease progression. The increased cell-cell interacti...
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 9th Annual Event in the Drug Discovery & Development...
Labroots and the Cell Biology Planning Committee are pleased to announce the 10 th Annual Event in the Cell Biology Virtual Event Series 2026 on September 16th, 2026 . This event provides an...
Labroots and the Cell Biology Planning Committee are pleased to announce the 9 th Annual Event in the Cell Biology Virtual Event Series 2025 on September 17th, 2025 . This event provides an...
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 8 th Annual Event in the Drug Discovery & Development...
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 9th Annual Event in the Drug Discovery & Development...
Labroots and the Cell Biology Planning Committee are pleased to announce the 10 th Annual Event in the Cell Biology Virtual Event Series 2026 on September 16th, 2026 . This event provides an...
Labroots and the Cell Biology Planning Committee are pleased to announce the 9 th Annual Event in the Cell Biology Virtual Event Series 2025 on September 17th, 2025 . This event provides an...
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 8 th Annual Event in the Drug Discovery & Development...
Labroots and the Cell Biology Planning Committee are pleased to announce the 8th Annual Event in the Cell Biology Virtual Event Series 2024 , providing an opportunity to discuss recent disco...
With the FDA expecting to approve 10–20 cell and gene therapies (CGT) per year by 2025, it is evident that the field will continue to hold immense commercial and medical opportunities....
Labroots and the Drug Discovery planning committee are pleased to announce its 7th Annual Event in the Drug Discovery & Development Virtual Event Series . Labroots will host this online-...
More than 90% of therapeutic candidates fail to make it past phase III clinical trials, mainly due to the lack of adequate, advanced cell models to provide in-depth predictive insights that...